Allurion Technologies, Inc. Stock-Based Compensation
Allurion Technologies, Inc. (ALUR) reported Stock-Based Compensation of $638.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-05-15
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $638.00K, a 28.87% decline year-over-year.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $702.00K, a 16.33% decline year-over-year.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $531.00K, a 38.26% decline year-over-year.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $1.02M, a 26.21% increase year-over-year.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $3.15M, a 2.95% increase from fiscal 2024.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $3.06M, a 63.43% decline from fiscal 2023.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $8.36M, a 1812.36% increase from fiscal 2022.
- Allurion Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $437.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $638.00K 10-Q · filed 2026-05-15 | $1.34M derived: sum of 2 quarters · filed 2026-05-15 | $1.87M derived: sum of 3 quarters · filed 2026-05-15 | $2.89M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.23M derived: sum of 2 quarters · filed 2026-03-30 | $2.25M derived: sum of 3 quarters · filed 2026-03-30 | $3.15M 10-K · filed 2026-03-30 |
| 2025-09-30 | $531.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $1.55M derived: sum of 2 quarters · filed 2025-11-17 | $2.44M 10-Q · filed 2025-11-17 | $3.28M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $1.91M 10-Q · filed 2025-08-19 | $2.75M derived: sum of 3 quarters · filed 2026-05-15 | $3.61M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $897.00K 10-Q · filed 2026-05-15 | $1.74M derived: sum of 2 quarters · filed 2026-05-15 | $2.60M derived: sum of 3 quarters · filed 2026-05-15 | $3.40M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.70M derived: sum of 2 quarters · filed 2026-03-30 | $2.50M derived: sum of 3 quarters · filed 2026-03-30 | $3.06M 10-K · filed 2026-03-30 |
| 2024-09-30 | $860.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | $1.67M derived: sum of 2 quarters · filed 2025-11-17 | $2.22M 10-Q · filed 2025-11-17 | $4.22M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $805.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $1.36M 10-Q/A · filed 2025-08-28 | $3.37M derived: sum of 3 quarters · filed 2025-08-28 | $8.90M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $552.00K 10-Q/A · filed 2025-08-28 | $2.56M derived: sum of 2 quarters · filed 2025-08-28 | $8.10M derived: sum of 3 quarters · filed 2025-08-28 | $8.50M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $2.01M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $7.55M derived: sum of 2 quarters · filed 2025-08-28 | $7.95M derived: sum of 3 quarters · filed 2025-08-28 | $8.36M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $5.54M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | $5.94M derived: sum of 2 quarters · filed 2025-08-28 | $6.35M 10-Q/A · filed 2025-08-28 | $6.53M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $401.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $810.00K 10-Q/A · filed 2025-08-28 | $992.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.08M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $409.00K 10-Q/A · filed 2025-08-28 | $591.00K derived: sum of 2 quarters · filed 2025-08-28 | $684.00K derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | $182.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $275.00K derived: sum of 2 quarters · filed 2025-08-28 | $437.00K 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $255.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $162.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |